T. Gu

发表

Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study

Pan Wang, Xin Liu, Jiali Chen, 2022, Hepatology International.

Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer.

D. Camidge, J. Jansen, J. Penrod, 2020, Journal of comparative effectiveness research.

Identification and validation of neurotrophic factor-related genes signature in HNSCC to predict survival and immune landscapes

Guobin Song, Gang Tian, Yunfei Liu, 2022, Frontiers in Genetics.

External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis

Kun He, Jiali Chen, Yunwei Han, 2022, Clinical and Experimental Medicine.

PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study

Kun He, Jiali Chen, Jing Wang, 2022, Frontiers in Immunology.

Evaluation of Lactate Dehydrogenase and Alkaline Phosphatase as Predictive Biomarkers in the Prognosis of Hepatocellular Carcinoma and Development of a New Nomogram

Juan Song, Yunwei Han, Lu Guo, 2023, Journal of hepatocellular carcinoma.

Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study

Kun He, Han Li, Yunwei Han, 2023, Journal of hepatocellular carcinoma.

Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: a large, multicenter study.

Yi Jiang, Kun He, Yunwei Han, 2023, Annals of hepatology.

Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study

Kun He, Yunwei Han, Lu Guo, 2023, Journal of Cancer Research and Clinical Oncology.

Health care resource utilization (HCRU) and total costs of care (TCOC) among patients (pts) with diffuse large B-cell lymphoma (DLBCL) treated with chimeric antigen receptor (CAR) T-cell therapies in the United States: An analysis of four claims databases.

A. McBride, C. Pelletier, M. Jun, 2020, Journal of Clinical Oncology.

P1.12-21 Developing a Real-World 3L Comparator to CheckMate 032: Overall Survival (OS) in Patients with Small Cell Lung Cancer (SCLC)

J. Penrod, G. Selvaggi, L. Schwartzberg, 2018, Journal of Thoracic Oncology.